KLIFO A/S: Financial statements 2014
CVR: 18196131
Source: annual report 2014, Danish Business Authority
01/01/2014 – 31/12/2014
KLIFO A/S (CVR 18196131) has filed annual accounts for 2014. In 2014, the company reported a gross profit of DKK 20,529,807 and a net result of DKK 2,176,393 compared with DKK 2,140,492 the year before. That is an increase of 22.1% compared with the year before. Equity in the 2014 report amounted to DKK 5,714,808. The solvency ratio was 36.7%.
- Gross Profit
- DKK 20,529,807
- Profit/Loss
- DKK 2,176,393
- Equity
- DKK 5,714,808
- Total Assets
- DKK 15,575,203
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2014 | - | 20.5 mio. | 2.2 mio. | 5.7 mio. | - |
| 2013 | - | 16.8 mio. | 2.1 mio. | 5 mio. | - |
| 2012 | - | 13.7 mio. | 393 t. | 3.1 mio. | - |
Official annual report
Screen every Danish company
Combine filters on financials, industry, geography, property and risk, and instantly see which companies match.
Try company screeningEvents in 2014
As of October 1, 2014, Morten Nielsen has joined the board of directors of KLIFO A/S.
As of October 1, 2014, Thor-Björn Gunnar Conradsson has left the board of directors of KLIFO A/S.
KLIFO A/S has published its annual report for 2013. Gross profit came to DKK 16,819,053, and the net result was DKK 2,140,492.
About KLIFO A/S
KLIFO A/S is a Danish company of the type Aktieselskab based in Brøndby, founded in 1994. The company is registered under the industry Forskning og eksperimentel udvikling inden for naturvidenskab og teknik. The management consists of René Holmen Pedersen. The board consists of Niels Peder Nielsen (chair), Alejandra Maria Cristina Bonifacini Mørk, Rafael Natanek and Redmar Koene. The company is owned by Drug Development Consulting BidCo ApS. The company has 114 employees (2026). In 2025, the company reported a gross profit of DKK 84,066,000 and a net result of DKK -47,419,000 compared with DKK -128,000 the year before. Equity in the 2025 report amounted to DKK 16,135,000.